Purchase Order 75N93024P01076

Award Date 8/30/24
Potential Completion Date 1/31/25
Potential Value $83K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health, to 10X Genomics, Inc. The $242,710.00 firm fixed price purchase order is for 10X Chromium Controller, Next GEM Single Cell Reagents, and associated instrumentation and supplies to support NIAID's research efforts on antigen-specific B-cell responses and how immune cells are affected by residual viral...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $26,385.50 firm fixed price purchase order to 10X Genomics, Inc. for single cell analysis kits and reagents. The award is pursuant to Request for Quotes RFQ-NIAID-23-2177598 and has a total small business set aside designation. Under the contract, 10X Genomics will provide Chromium Next GEM Chip K Single Cell Kits, Library Construction Kits, Chromium Single Cell Mouse TCR Amplification Kits, and...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a firm fixed price purchase order to 10X Genomics, Inc., a small business, for the delivery of various Chromium kits. The $13,969.00 contract provides a range of 10X Genomics' single-cell and spatial transcriptomics products and services, including library construction kits, single cell 5' kits, feature barcode kits, TCR/BCR amplification kits, and dual index kits. The...
This purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. for $75,021 to deliver specific Chromium NextGEM Single Cell sequencing kits required by the Center for Human Immunology (CHI) for ongoing immunome profiling projects. The solicitation requested quotes for 16 reactions of the Chromium NextGEM Single Cell 3' Kit v3.1, 48 reactions each of the Chromium NextGEM Chip H...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $169,774 firm fixed price purchase order to 10X Genomics, Inc. for CHROMIUM NEXTGEM SINGLE CELL REAGENT KITS. The place of performance is 10X Genomics' Pleasanton, California facility. The period of performance is from September 7, 2023 through December 29, 2023. This contract has a total small business set aside designation. 10X Genomics will deliver its...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $20,035.00 firm-fixed-price purchase order to 10X Genomics, Inc. for the supply of Chromium Kits for single-cell analysis. This acquisition was conducted as a small business set-aside under NAICS code 325414, Biological Product (except Diagnostic) Manufacturing. The purchase order includes the Chromium GEM-X Single Cell 3' Kit v4 and Chromium GEM-X Single Cell 3' Chip Kit...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $85,202 purchase order to 10X Genomics, Inc. for the supply of CHROMIUM NEXT GEM SINGLE CELL MULTIOME ATAC + GENE EXPRESSION REAGENT BUNDLE kits. The solicitation sought quotes for two kits containing reagents to examine the transcriptomic state and cell surface proteome of human skin and blood immune cells from healthy and disease donors using an existing...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to 10X Genomics, Inc. to provide various Chromium Next GEM reagents and kits for single-cell and spatial analysis applications. The $130,852.50 contract has a small business set-aside designation and will support biomedical research efforts at NIH's Laboratory of Immune System Biology (LISB). The award was made...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $121,907.12 firm-fixed-price purchase order to 10X Genomics, Inc. for the delivery of various chromium kits for single-cell and spatial analysis applications. The kits include products for single-cell ATAC sequencing, single-cell RNA sequencing, and multiplex sample indexing. The award was made under a small business set-aside solicitation, with 10X...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to 10X Genomics, Inc. for the procurement of various Chromium kits, including Chromium X & Accessory kits, Chromium GEM-X Single Cell 5' kits, and Dual Index kits. This $84,005.00 contract has a total small business set-aside designation. The contract provides these specialized genomics reagents and kits to further NIAID's biomedical research efforts, particularly in the areas...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a $83,135.00 firm fixed price purchase order contract to 10X Genomics, Inc. for 10X Chromium Controller, Next Gen Single Cell Reagents. This contract is set aside for small businesses.

The award is for the supply of 10X Genomics' Chromium Single Cell 5' Reagent Kits, Library Construction and Barcoding Kits, B Cell and T Cell VDJ (BCR & TCR) Enrichment Kits, and Single Index Kits. These products and services will support NIAID's Laboratory of Immunoregulation's research efforts to understand cellular and molecular mechanisms regulating the human immune response, specifically analyzing antigen-specific B-cell responses and the impact of HIV and SARS-CoV-2 on immune cells. The contract has a period of performance through January 31, 2025.

Generated 8/30/24, 7:05 PM